2011 (v1)
Publication
No description
Uploaded on: April 14, 2023
-
-
May 26, 2020 (v1)Publication
EXECUTIVE SUMMARY Background Fetal growth restriction (FGR), also known as intrauterine growth restriction (IUGR), is a common complication of pregnancy that has been associated with a variety of adverse perinatal outcomes. There is a lack of consensus regarding terminology, etiology, and diagnostic criteria for FGR and neonatal outcomes, with...
Uploaded on: April 14, 2023 -
2013 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2014 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2014 (v1)Publication
To assess the efficacy of preoperative treatment with aromatase inhibitors (AIs) in premenopausal women undergoing laparoscopic myomectomy of large uterine myomas.Prospective non-randomized assessor-blind comparative trial.This study included 80 patients undergoing laparoscopic myomectomy of large uterine myomas (≥8cm). Forty patients were...
Uploaded on: March 27, 2023 -
2013 (v1)Publication
Introduction: Imidafenacin (KRP-197/ONO-8025) is the latest antimuscarinic (AM) developed for the treatment of overactive bladder syndrome (OAB) and, at the moment, it is marketed only in Japan. This compound has been developed to improve the tolerability of AM therapy by binding specifically the M3 receptor subtype, thus limiting undesirable...
Uploaded on: April 14, 2023 -
2017 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2014 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2014 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2013 (v1)Publication
OBJECTIVE: To assess the efficacy of norethindrone acetate (NETA) for the treatment of pain symptoms caused by rectovaginal endometri- osis in depressed patients (group D) and in non-depressed controls (group N). DESIGN: Open-label assessor-blinded prospective comparative study. MATERIALS AND METHODS: Patients were treated with NETA (2.5...
Uploaded on: April 14, 2023 -
2013 (v1)Publication
Introduction: Desogestrel (DSG) is a third-generation progestin. It is commonly used in various formulations for hormonal contraception including combinations with ethinyl estradiol (EE), progestin-only pill and subdermal implants. DSG is also used in menopausal patients for hormone replacement therapy (HRT). Areas covered: The current...
Uploaded on: April 14, 2023 -
2015 (v1)Publication
Objective The aims of this study were evaluation of the association of reduced fetal movements (RFM) and small-for-gestational-age (SGA) birth at term and to explore if fetal and maternal outcomes are different with single vs repeated episodes of RFM and normal fetal assessment test results. Study Design This was a retrospective cohort study of...
Uploaded on: April 14, 2023 -
2014 (v1)Publication
No description
Uploaded on: April 14, 2023